A complication risk score to evaluate clinical severity of thalassaemia syndromes.

British Journal of Haematology
Angela VitranoAurelio Maggio

Abstract

The thalassaemia syndromes (TS) show different phenotype severity. Developing a reliable, practical and global tool to determine disease severity and tailor treatment would be of great value. Overall, 7910 patients were analysed with the aim of constructing a complication risk score (CoRS) to evaluate the probability of developing one or more complications. Nine independent variables were included in the investigation as predictors. Logistic regression models were used for Group A [transfusion-dependent thalassaemia (TDT)], Group B [transfused non-TDT (NTDT)] and Group C (non-transfused NTDT). Statistically significant predictors included age (years), haemoglobin levels, hepatic transaminases [alanine aminotransferase (ALT) and aspartate aminotransferase] and left-ventricular ejection fraction (LVEF) for Group A; age (years), age at first chelation (months), ALT and LVEF for Group B; and age (years), mean serum ferritin (SF) levels and LVEF for Group C. The area under the receiver operating characteristic curve was 84·5%, 82·1% and 80·0% for Groups A, Group B and Group C respectively, suggesting the models had good discrimination. Finally, the CoRS for each group was categorised into four risk classes (low, intermediate, high, ...Continue Reading

References

Mar 17, 2006·Hemoglobin·Andrea MancusoAurelio Maggio
Jun 24, 2008·Bulletin of the World Health Organization·Bernadette Modell, Matthew Darlison
May 25, 2010·Orphanet Journal of Rare Diseases·Renzo Galanello, Raffaella Origa
May 3, 2013·Cold Spring Harbor Perspectives in Medicine·Swee Lay Thein
Jun 5, 2013·Haematologica·Khaled M MusallamEliezer A Rachmilewitz
Jul 6, 2014·British Journal of Haematology·Caterina Borgna-PignattiStefano Volpato
May 18, 2016·Annals of the New York Academy of Sciences·Antoine N Saliba, Ali T Taher
May 28, 2017·Haematologica·Achille IolasconUNKNOWN Working Study Group on Red Cells and Iron of the EHA
Aug 5, 2017·Lancet·Ali T TaherMaria Domenica Cappellini
Dec 10, 2017·Hematology·Ali T Taher, Antoine N Saliba
Dec 10, 2017·Hematology·M Domenica Cappellini, Irene Motta
Apr 11, 2018·Pediatric Blood & Cancer·Elliott VichinskyJanet L Kwiatkowski
Oct 30, 2019·Expert Review of Hematology·Irene MottaMaria Domenica Cappellini

❮ Previous
Next ❯

Citations

Nov 9, 2021·British Journal of Haematology·Deborah Rund

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.